Angina Angina Pectoris Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $1250

15:17 EDT 1 Aug 2017 | BioPortfolio Reports

DelveInsight's, Angina Angina Pectoris Pipeline Insights, 2017, report provides comprehensive insights about pipeline drugs across this Angina Angina Pectoris. The key objective of the report is to establish the understanding for all the pipeline drugs that are undergoing research across Angina Angina Pectoris. This report provides information on the therapeutic development for Angina Angina Pectoris, dealing with all the pipeline drugs and comparative analysis at various stages covering all clinical, preclinical as well as discovery products. The report further contains details on dormant products and discontinued products. Therapeutic assessment of all the active products by route of administration and molecule type is also covered in this report.
The report is built using data and information sourced from proprietary databases, primary and secondary research and inhouse analysis by DelveInsight team of industry experts.
Secondary sources information and data has been collected from various printable and nonprintable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.
Amgen Inc.
Asahi Kasei Pharma Corp.
Bayer Healthcare
Boehringer Ingelheim
Cytokinetics Inc.
Eisai Co Ltd.
Green Cross Corp.
Juventas Therapeutics Inc.
Korea Otsuka Pharmaceutical Co. Ltd
Kuhnil Pharmaceutical Co. Ltd.
Lectus Therapeutics Ltd
Lee's Pharmaceutical Holdings Ltd.
Milestone Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Resverlogix Corp
Searle and Co.
Shire Plc
Taxus Cardium Pharmaceuticals Group Inc.
TSH Biopharm Corporation Limited
ViroMed Co Ltd
Viron Therapeutics Inc

Angina Angina Pectoris Pipeline Drugs
Angina Angina Pectoris Pipeline Assessment
Angina Angina Pectoris Pipeline Analysis
Angina Angina Pectoris Drugs under Development
Angina Angina Pectoris Discovery drugs
Angina Angina Pectoris Preclinical drugs
Angina Angina Pectoris Phase I drugs
Angina Angina Pectoris Phase II drugs
Angina Angina Pectoris Phase III Pipeline Drugs Assessment
Angina Angina Pectoris Preregistration drugs
Angina Angina Pectoris Molecules in pipeline

Original Article: Angina Angina Pectoris Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $1250


More From BioPortfolio on "Angina Angina Pectoris Pipeline Insight, 2017 [Report Updated: 10072017] Prices from USD $1250"

Quick Search

Relevant Topics

Acute Coronary Syndromes ACS
Acute Coronary Syndromes (ACS) is an umbrella term for situations where the blood supplied to the heart muscle is suddenly blocked. Treatment for acute coronary syndrome includes medicines and a procedure known as angioplasty, during which doctors inflat...

Cardiovascular disease (CVD)
Acute Coronary Syndromes (ACS) Blood Cardiovascular Dialysis Hypertension Stent Stroke Vascular Cardiovascular disease (CVD) includes all the diseases of the heart and circulation including coronary heart disease (angina...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...